-pitant
Drugs that block the NK1 (substance P) receptor, used against nausea.
- Drugs ending in -pitant: 15
- Approved somewhere: 5
- With a US drug page: 3
Approved and clinical-stage drugs in ChEMBL whose names ending in -pitant, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Aprepitant | Approved | TACR1 | Neurokinin 1 receptor antagonist |
| Rolapitant | Approved | TACR1 | Neurokinin 1 receptor antagonist |
| Tradipitant | Phase 3 | TACR1 | Neurokinin 1 receptor antagonist |
| Fosaprepitant | Approved | TACR1 | Neurokinin 1 receptor antagonist |
| Fosnetupitant | Approved | TACR1 | Neurokinin 1 receptor antagonist |
| Netupitant | Approved | TACR1 | Neurokinin 1 receptor antagonist |
| Casopitant | Phase 3 | TACR1 | Neurokinin 1 receptor antagonist |
| Burapitant | Phase 2 | TACR1 | Neurokinin 1 receptor antagonist |
| Orvepitant | Phase 2 | TACR1 | Neurokinin 1 receptor antagonist |
| Serlopitant | Phase 2 | TACR1 | Neurokinin 1 receptor antagonist |
| Vestipitant | Phase 2 | TACR1 | Neurokinin 1 receptor antagonist |
| Vofopitant | Phase 2 | TACR1 | Neurokinin 1 receptor antagonist |
| Ezlopitant | โ | TACR1 | Neurokinin 1 receptor antagonist |
| Figopitant | โ | TACR1 | Neurokinin 1 receptor antagonist |
| Maropitant | โ | TACR1 | Substance-P receptor antagonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO